Phase I study of everolimus (E, RAD001) and ganitumab (G, AMG 479) in patients (pts) with advanced solid tumors
Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Strother, Robert Matthew⋅Strother, Robert Matthew⋅Strother, Robert Matthew⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Prasad, Nagendra K⋅Prasad, Nagendra K⋅Prasad, Nagendra K⋅Berry, William⋅Berry, William⋅Berry, William⋅Jones, David R⋅Jones, David R⋅Jones, David R⋅Younger, Anne⋅Younger, Anne⋅Younger, Anne⋅Funke, Jennifer M⋅Funke, Jennifer M⋅Funke, Jennifer M⋅Detty, Tammi⋅Detty, Tammi⋅Detty, Tammi⋅Althouse, Sandra⋅Althouse, Sandra⋅Althouse, Sandra⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Chiorean, E. Gabriela⋅Chiorean, E. Gabriela and Chiorean, E. Gabriela
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 2529, 2013-05-20. | Journal Article